Tang Capital Management Discloses Moves into La Jolla Pharmaceutical Company (LJPCD), Vanda Pharmaceuticals Inc. (VNDA), Mirati Therapeutics Inc. (MRTX) & Others

Tang Capital Management, led by Kevin C. Tang, revealed in a filing several moves that have impacted its equity portfolio. One of the companies involved is La Jolla Pharmaceutical Company (OTCBB:LJPCD) in which the fund now owns 468,214 shares, which represent 9.9% of the company’s common stock. La Jolla Pharmaceutical develops therapeutics, targeting significant unmet life-threatening diseases.

The amount of shares of La Jolla Pharmaceutical Company held by Tang has been decreased amid a reverse stock split announced by the company a couple of days ago. Earlier, the fund reported holding around 1.51 million shares of La Jolla Pharmaceutical. The reverse stock split was made under the 1-for-50 ratio. The restructuring has been conducted in order to place the company for a possible listing on the NASDAQ stock market, the company said in a statement.

In another filing, the fund revealed that it has disposed of all the shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA). Earlier, Tang held 1.81 million shares, disclosed by the fund in an earlier filing.  Vanda Pharmaceuticals is a biopharmaceutical company, that develops and commercialize products which helps cure central nervous system disorders.

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Baker Bros. Advisors, managed by Julian Baker And Felix Baker, raised its stake in Vanda Pharmaceuticals by 22% in the third quarter of 2013, and currently owns some 4.79 million. William Leland Edwards’s Palo Alto Investors also holds 2.91 million shares of the company.

The fund also revealed that it owns 471,764 shares of Supernus Pharmaceuticals Inc (NASDAQ:SUPN), equal to 1.4% common stock of the company, down from 2.3 million shares held earlier.

Supernus Pharmaceuticals, is a specialty pharmaceutical company, that develops and commercializes products which helps in the treatment of central nervous system, or CNS, diseases. Philip Hempleman’s Ardsley Partners initiated a position in Supernus Pharmaceuticals Inc (NASDAQ:SUPN), by purchasing 1.93 million shares. In October, Orchard Hill Capital Management also disclosed a filing, that it holds 10.2% of the company’s shares. Samuel Isaly’s Orbimed Advisors, owns some 639,400 shares of the company.

In another filing, Tang Capital Management revealed that it has sold all the common shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH). Previously, Tang owned some 11.47 million shares, equal to 8.2% of the company.

Anthera Pharmaceuticals is a biopharmaceutical company, it develops and commercializes products that cure autoimmune diseases. Of the other hedge funds we track, Deerfield Management, led by James E. Flynn, holds 1.69 million shares of Anthera Pharmaceuticals, worth $6.80 million. Samuel Isaly’s Orbimed Advisors is also bullish on the company and owns 932,750 shares.

Tang Capital Management also disclosed in another filing, that it has trimmed its stake in Mirati Therapeutics, Inc. (NASDAQ:MRTX), to 774,375 shares, from 1.18 million shares, held at the end of the third quarter of 2013. The fund currently holds a stake of 5.8% of the common stock of the company.

Baker Bros. Advisors, is also bullish on Mirati Therapeutics, Inc. (NASDAQ:MRTX), and holds 1.98 million shares. Mirati Therapeutics, Inc. (NASDAQ:MRTX) is a clinical-stage biopharmaceutical company that develops a pipeline of targeted oncology products. Orbimed Advisors, managed by Samuel Isaly, initiated a position in the company in the third quarter of 2013 and now holds some 1.15 million shares.

Disclosure: none

Recommended Readings:

Mario Gabelli is Bullish on The Bon-Ton Stores, Inc. (BONT) & Ups Stake to 8.12%

Moab Capital Partners Closes Stake in Mac-Gray Corporation (TUC) Following Merger

Hedge Fund News: Bill Ackman, Tom Sandell & Relational Investors

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!